FDA Accepts Ascendis Pharmas Supplemental Biologics License Application for TransCon hGH for the Treatment of Adults with Growth Hormone Deficiency

ASND Stock  USD 139.70  3.32  2.43%   
About 59% of all Ascendis Pharma's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Ascendis Pharma AS suggests that some traders are interested. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.
  
PDUFA goal date is July 27, 2025COPENHAGEN, Denmark, Dec. 12, 2024 -- Ascendis Pharma AS today announced that the U.S. Food Drug Administration has accepted for review its supplemental Biologics License Application in adult growth hormone deficiency for TransCon hGH . The FDA set a Prescription Drug User Fee Act goal date of July 27, 2025. This marks another step toward

Read at finance.yahoo.com
Yahoo News
  

Ascendis Pharma Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Ascendis Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ascendis Pharma Fundamental Analysis

We analyze Ascendis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ascendis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ascendis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

Ascendis Pharma is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Ascendis Pharma AS Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ascendis Pharma stock to make a market-neutral strategy. Peer analysis of Ascendis Pharma could also be used in its relative valuation, which is a method of valuing Ascendis Pharma by comparing valuation metrics with similar companies.

Peers

Ascendis Pharma Related Equities

BGNEBeiGene   2.21   
0%
65.0%
ACLXArcellx   1.65   
0%
48.0%
REPLReplimune   1.30   
0%
38.0%
PLRXPliant Therapeutics   0.98   
0%
28.0%
AKROAkero Therapeutics   0.67   
0%
19.0%
MDGLMadrigal Pharmaceuticals   0.36   
0%
10.0%
APLSApellis Pharmaceuticals   0.33   
0%
9.0%
BPMCBlueprint Medicines   0.21   
0%
6.0%
CRNXCrinetics Pharmaceuticals   0.04   
1.0%
0%
DAWNDay One   0.16   
4.0%
0%
NUVLNuvalent   0.44   
12.0%
0%
STOKStoke Therapeutics   0.60   
17.0%
0%
ETNB89bio   0.63   
18.0%
0%
UTHRUnited Therapeutics   0.76   
22.0%
0%
AMLXAmylyx Pharmaceuticals   1.72   
50.0%
0%
VTYXVentyx Biosciences   3.40   
100.0%
0%

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum